A healthier world needs a strong foundation – one that establishes quality, sets the bar for scientific rigor and technological progress, and epitomizes collaboration between industry, nonprofits, government and academia.
From the standards we create to the partnerships and conversations we foster, our scientists, advocates and network of experts are critical to constructing and reinforcing this foundation to ensure people stay healthy.
Latest Standards Updates
Five New Revision Bulletins (posted 27–Dec–2019)
Three New Pending Notices of Intent to Revise (posted 27–Dec–2019)
Three New Notices of Intent to Revise (posted 27–Dec–2019)
One New General Chapter Prospectus (posted 27–Dec–2019)
One New General Announcement (posted 27–Dec–2019)
Cumulative List Updated (posted 27–Dec–2019)
Quality Matters Blog
With significant innovations in pharmaceuticals, including biologic drugs and treatments for rare diseases, the need for new and better functioning excipients to improve drug delivery is growing.
Consistent quality. Greater access. They’re what patients deserve and what USP strives to ensure across the globe through the development of public quality standards.
USP standards have evolved to accommodate medicines of all types. The biosimilar paradigm may ultimately resemble that of generic drugs.